Navigation Links
sulodexide in Medical Technology

Keryx Biopharmaceuticals Completes SUN-MICRO Phase 3 Pivotal Trial

...ral gelcap) PHASE 3 and PHASE 4 CLINICAL PROGRAM sulodexide is in a pivotal Phase 3 and Phase 4 clinical progr... The clinical plan to support an NDA approval for sulodexide under Subpart H (accelerated approval), as agreed ...FDA, as a condition to the accelerated approval of sulodexide based on the Phase 3 clinical trial, that the Phas...

Sulodexide Data Safety Monitoring Committee Completes Additional Review of Phase 3 Study Data

... No Safety Concerns Raised sulodexide Phase 3 study to continue without modification NEW YORK, Dec. 5 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals (Nasdaq: KERX ) today announced ...

Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Mechanism of Action and Clinical Activity of Sulonex(TM) (sulodexide oral gelcap) at the Upcoming American Diabetes Association 67th Scientific Sessions in Chicago, Illinois

...ditional abstracts of interest include: 2220 - Oral Administration of sulodexide for the Treatment of Diabetic Nephropathy in a Phase II Study has Mini... AZ, Washington, DC, Baltimore, MD 2376 - Efficacy and Safety of sulodexide in the Treatment of Diabetic Nephropathy RAM WEISS, ROBERT M. NIECEST...
sulodexide in other areas

Sulodexide - Wikipedia, the free encyclopedia

Sulodexide is a highly purified mixture of glycosaminoglycans composed of low molecular weight heparin (80%) and dermatan sulfate (20%).

Sulodexide reduces UAER in DN

: Sulodexide, a low-molecular-weight heparin that can be given orally, is ... The fact that sulodexide is capable of normalizing urine albumin excretion rates ...

Oral Sulodexide Reduces Albuminuria in Microalbuminuric and ...

Sulodexide is a glycosaminoglycan, a new class of drug that has demonstrated ... Treatment with 200 mg/d sulodexide for 4 mo significantly reduced log albumin ...

Sulodexide in the treatment of intermittent claudication. Results of a ...

patients was used to evaluate the usefulness of sulodexide, a ... sulodexide was its thrombogenesis-inhibiting properties, ... allocated to receive sulodexide ...

Effect of Sulodexide in Overt Diabetic Nephropathy - Full Text View ...

Sulodexide belongs to a class of drugs called glycosaminoglycans (GAG) ... Sulodexide is approved in Europe to treat vascular indications. ...

Clinical trial: Sulodexide to Treat Type 2 Diabetic Nephropathy

Sulodexide may protect the kidneys by preventing these chemical changes. ... Prior exposure to sulodexide, either in a clinical setting or as a participant ...
Other Tags
(Date:1/22/2015)... (PRWEB) January 22, 2015 Blue Cross and ... Minnesotans who exemplify what it means to “Live Fearless.” ... for people to share their stories about how they or ... simply inspired others by living in the moment. By telling ...
(Date:1/22/2015)... New York, New York (PRWEB) January 22, 2015 ... filed after Fresenius Medical Care recalled its GranuFlo ... the federal multidistrict litigation underway in U.S. District Court, ... an Order dated January 20th, the Court has remanded ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Lower-Auto-Insurance.com has released a ... kit in a car for reducing the costs of an ... will also be able to get lower prices for their vehicle ... an important role in determining policy costs. Because of this, ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
(Date:12/22/2014)... Dec. 22, 2014 Research and Markets ... the "The Global Watermarking and Fingerprinting Markets" ... http://photos.prnewswire.com/prnh/20130307/600769 This insight ... watermarking and fingerprinting markets. Watermarking aims to control ...
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
(Date:12/17/2014)... Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) has ... Market 2015-2019" report to their offering. ... trend upcoming in this market is the increasing demand ... in recording of patient data for quick and correct ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
Other Contents